MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia (MENJAGA)
An Implementation Trial of Continuous Quality Improvement for Antenatal Syphilis, HIV and Hepatitis B Detection and Treatment in Indonesia
Sponsor: Kirby Institute
Listed as NCT06058286, this NA trial focuses on Hepatitis B and Hiv and remains ongoing. Sponsored by Kirby Institute, it has been updated 6 times since 2023, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Nov 2025 — Present [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Sep 2025 — Nov 2025 [monthly]
Not Yet Recruiting NA
-
Feb 2025 — Sep 2025 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Oct 2023 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Kirby Institute
- London School of Hygiene and Tropical Medicine
- Yanri Wijayanti Subronto, MD, PhD,
For direct contact, visit the study record on ClinicalTrials.gov .